Search
Search Results
##search.searchResults.foundPlural##
-
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
3030PDF: 1414HTML: 179 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3467PDF: 1014HTML: 4642 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4459PDF: 2040HTML: 5548Table 1: 287 -
-
-
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
2017PDF: 1100HTML: 257 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1350PDF: 576HTML: 23241 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2823PDF: 834HTML: 2334 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1518PDF: 868HTML: 1038 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2608HTML: 343PDF: 970 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3599PDF: 860HTML: 3033Figure 1a and 1b: 201Figure 2: 211Figure 3: 217Figure 4: 209Figure 5: 205Tables 1-5: 185 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3315PDF: 1203HTML: 1695Untitled: 224Untitled: 228Untitled: 215 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3463PDF: 1042HTML: 3022 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2312PDF: 2026HTML: 536 -
-
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2593PDF: 882HTML: 489 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
4228PDF: 1183HTML: 922 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2388PDF: 944HTML: 2022Fig 1 Rossi: 249 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1563PDF: 564HTML: 209 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4995PDF: 1891HTML: 2885Untitled: 306 -
THE ROLE OF THE CAROTID DOPPLER EXAMINATION IN THE EVALUATION OF ATHEROSCLEROTIC CHANGES IN BETA THALASSEMIA PATIENTS
2311PDF: 1053HTML: 3073Untitled: 277 -
-
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1308PDF: 804Html: 125 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
938PDF: 167HTML: 231 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3909PDF: 1180HTML: 2505Figure 1: 248 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1664PDF: 1097HTML: 148 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
783PDF: 505HTML: 6290 -
CANDIDEMIA IN PATIENTS WITH ACUTE LEUKEMIA: ANALYSIS OF SEVEN YEARS’ EXPERIENCE AT A SINGLE CENTER IN CHINA Candidemia in acute Leukemia
1870PDF: 1004HTML: 269 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2375PDF: 791HTML: 373







